Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (2722)	11/11/1997 5:51:00 PM
From: Joe E.	of 6136

<<Just bought more at 41 1/4. Do I assume that you all agree that this is a cheap price for AGPH and it's rather unlikely that the price is going lower? After all, this is 82+ pre-split, which would have been a bargain. The price is still about 15 off from it's high. Any ideas out there?>> I think that is a very good price, about 25% under fair value, by my calcs. Is there maybe some news out of one of the medical conferences underway now that impacts AGPH? It would have to be an impact on one of the development stage drugs, I guess. The alternative read (probably most correct) is Fortovase, which would be a misread of the market for protease inhibitors. I took the opportunity to uncover some covered calls, so I agree this is a buying opportunity.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next